未找到相关数据
Diversifying clinical trials
被引：17
作者：
不详
机构：
关键词：
D O I：
10.1038/s41591-018-0303-4
中图分类号：
Q5 [生物化学];
Q7 [分子生物学];
学科分类号：
071010 ;
081704 ;
摘要：
Scientific common sense and social justice dictate that the safety and efficacy of new therapies must be tested in the patient populations in need of treatment. Yet a recent study found that African Americans have been dramatically underrepresented in US clinical trials for cancer drugs. Efforts to increase the participation of minorities in clinical trials must become a priority for all drug developers.
引用
收藏
页码：1779 / 1779
页数：1
相关论文